From: Clinical manifestation, staging and prognosis of hepatocellular carcinoma in Gambian patients
 | HCC with positive HBsAg (n = 170) | HCC with negative HBsAg (n = 86) | P value |
---|---|---|---|
Age(yrs)Mean | 39.9 | 51.4 | < 0.0001 |
Age groups | |||
 < 35 | 59(34.7) | 13(15.1) | < 0.0001 |
 35–44 | 65(38.2) | 18(20.9) |  |
 45–54 | 28(16.5) | 19(22.1) |  |
 55–64 | 12(7.1) | 11(12.8) |  |
 ≥ 65 | 6(3.5) | 25(29.1) |  |
Sex (M:F) | 145(85.3):25(14.7) | 62(72.1):24(27.9) | 0.011 |
Clinical features | |||
 1. Constitutional symptoms | |||
  Fever | 143(84.1) | 69(79.1) | 0.480 |
  Night sweat | 116(68.2) | 54(62.8) | 0.414 |
  Weight loss | 154(90.5) | 79(91.9) | 0.723 |
  Easy fatiguability | 153(90) | 80(93) | 0.328 |
 2. GI symptoms | |||
  Abdominal pain | 156(91.8) | 68(79.1) | 0.002 |
  Early satiety | 150(88.2) | 75(87.2) | 0.801 |
  Abdominal distension | 139(81.8) | 66(76.7) | 0.329 |
  Anorexia | 137(80.6) | 63(73.3) | 0.170 |
  Nausea | 108(63.5) | 51(59.3) | 0.468 |
  Vomiting | 65(38.2) | 32(37.2) | 0.955 |
  Bloody stool | 49(28.8) | 24(27.9) | 0.922 |
  Diarrhoea | 64(37.6) | 24(27.9) | 0.112 |
  Yellow eyes | 78(45.9) | 29(33.7) | 0.042 |
  Dark urine | 117(68.8) | 46(53.5) | 0.018 |
  Pruritus | 50(29.4) | 27(31.4) | 0.677 |
  Oedema | 58(34.1) | 34(39.5) | 0.392 |
Medical history | |||
 Hypertension | 8(4.7) | 10(11.6) | 0.039 |
 Anaemia | 44(25.9) | 20(23.3) | 0.664 |
 Cigarette smoking | 68 (40) | 27 (31.4) | 0.215 |
 Alcohol | 11(6.4) | 5(5.8) | 0.865 |
Examination | |||
 Oedema | 53 (31.2) | 35( 40.7) | 0.100 |
 Jaundice | 54 (31.8) | 21(24.4) | 0.239 |
 Hepatomegaly | 132 (77.6) | 70 (81.4) | 0.236 |
 Splenomegaly | 19 (11.2) | 9 (10.5) | 0.887 |
 Ascites | 58 (34.1) | 29(33.7) | 0.973 |
 Collateral veins | 30 (17.6) | 13 (15.1) | 0.620 |
 Abdominal tenderness | 82 (48.2) | 22(25.6) | 0.001 |
Laboratory investigations | |||
 Alpha-fetoprotein (ng/ml) | 4780.48 (3- 116000) | 2527.46(1.07–94600) | 0.385 |
 Haemoglobin (g/dl) | 11.4( 4.8–18.4) | 11.2 ( 5.6–16.8) | 0.248 |
 White Cell Count (× 109/l) | 8.25( 1.8–34.8) | 7.6 (2.2- 27.8) | 0.238 |
 Red cell count (× 1012/l) | 4.21(0.9- 7.67) | 4.01(2.34–6.9) | 0.314 |
 Platelet count (× 109/l) | 207(33–941) | 252(52- 641) | 0.021 |
 Sodium (mmol/l) | 138(122–151) | 139(121–147) | 0.228 |
 Potassium (mmol/l) | 4.4(2.36–10.6) | 4.1(3.1–6.1) | 0.074 |
 Creatinine( umol/l) | 65( 13–949) | 68.5(37–744) | 0.247 |
 Glucose (mmol/l) | 4.45( 0.9–13.4) | 4.65(2.7–8.4) | 0.105 |
 Aspartate Transferase (U/L) | 224.5(32–7886) | 153(18–610) | < 0.001 |
 Alanine Transferase (U/L) | 71(5–937) | 47(8–271) | < 0.001 |
 Total Bilirubin (umol/l) | 37.5(0–646) | 25(6–273) | 0.0625 |
 Gamma glutamyl Transferase (U/L) | 305(14–1826) | 344(11–3677) | 0.851 |
 Alkaline phosphatase (U/L) | 281(28–4063) | 282(70–1902) | 0.820 |
 Albumin (g/L) | 33(15–52) | 33(20–45) | 0.551 |
Survival | |||
 Median survival (Days) | 31(1–448) | 41(3–510) | 0.175 |